Burroughs Wellcome Fund

Last updated
Burroughs Wellcome Fund
Founded1955;68 years ago (1955)
FocusBiological and Medical research and Science Education
Location
MethodFunding
Key people
Endowment US$782.7 million
Website www.bwfund.org

The Burroughs Wellcome Fund (BWF) is an American non-profit medical research organization that provides funding for biomedical research, STEM education, and areas of career development for scientists. [1] Since 1970, it has been headquartered in North Carolina's Research Triangle Park. [2]

Contents

Founded in 1955 as an extension of the England-based Wellcome Trust, the Burroughs Wellcome Fund's two-part mission is “to help scientists early in their careers develop as independent investigators” and “to advance fields in the basic biomedical sciences that are undervalued or in need of particular encouragement”. [3]

The fund grants more than $40 million each year to research focusing on infectious disease, biomedical science, and other health-related fields. The Fund also supports STEM education efforts in North Carolina, including the North Carolina Science, Mathematics, and Technology Education Center. [4]

History

The Burroughs Wellcome Fund was founded in 1955 as an American extension of the Wellcome Trust in England. These foundations trace their origins to the American pharmaceutical magnates Henry Wellcome and Silas Burroughs, who founded Burroughs Wellcome and Co. in England in 1880. This pharmaceutical company was one of the four large organizations that eventually merged to become GlaxoSmithKline.

After Silas Burroughs died in 1895, Henry Wellcome expanded the company into several continents and numerous countries, including the United States. In 1924, Wellcome consolidated all of the company's holdings under a corporate umbrella that he named The Wellcome Foundation Ltd. When he died in 1936, his will vested all of the corporate shares in a new charity entity – the Wellcome Trust. The Trust's purpose was to use profits from the Wellcome Foundation to advance research in medicine and medical history.

In 1955, Sir Henry Dale, one of the Trust's original trustees and its chair for 21 years, and William N. Creasy, president and chair of Burroughs Wellcome Co. USA, created a U.S. extension of the Wellcome Trust called the Burroughs Wellcome Fund. From 1955 to 1993, it operated as a corporate foundation to support scientific research. In 1993 a $400 million gift from the trustees allowed it to become an independent entity with no ties to the Wellcome Foundation or to GlaxoSmithKline, which by 2000 had purchased all shares of Wellcome Foundation. [4]

Activities

Since its founding, the BWF has funded medical and biological science research across the United States and Canada. This has mainly consisted of individual recognition and funding like the Investigator in the Pathogenesis of Infectious Disease Award, [5] the Physician-Scientist Institutional Award, [6] and the Innovation in Regulatory Science Award. [7] The BWF also supports larger research projects conducted by multiple teams, such as a report on "The Domestic and International Impacts of the 2009-H1N1 Influenza A Pandemic." [8]

One example of large-scale research supported in part by the fund was the genetic sequencing of Plasmodium falciparum, the parasite behind most malaria deaths. The BWF partnered with the World Health Organization and the Department of Defense to fund this research at the University of Pennsylvania. [9] In addition to financial support, the Fund facilitated collaboration among the research participants. [10]

The Fund is a sponsor of the North Carolina Teacher of the Year program through the North Carolina Department of Public Instruction. [11]

In 2013, BWF created the Innovation in Regulatory Science Award to fund regulatory science researchers in the U.S. and Canada. [12]

Related Research Articles

<span class="mw-page-title-main">Wellcome Trust</span> British healthcare research charity established in 1936

The Wellcome Trust is a charitable foundation focused on health research based in London, in the United Kingdom. It was established in 1936 with legacies from the pharmaceutical magnate Henry Wellcome to fund research to improve human and animal health. The aim of the Trust is to "support science to solve the urgent health challenges facing everyone." It had a financial endowment of £29.1 billion in 2020, making it the fourth wealthiest charitable foundation in the world. In 2012, the Wellcome Trust was described by the Financial Times as the United Kingdom's largest provider of non-governmental funding for scientific research, and one of the largest providers in the world. According to their annual report, the Wellcome Trust spent GBP £1.1Bn on charitable activities across their 2019/2020 financial year. According to the OECD, the Wellcome Trust's financing for 2019 development increased by 22% to US$327 million.

<span class="mw-page-title-main">Henry Wellcome</span> Anglo-American businessman

Sir Henry Solomon Wellcome was an American pharmaceutical entrepreneur. He founded the pharmaceutical company Burroughs Wellcome & Company with his colleague Silas Burroughs in 1880, which is one of the four large companies to eventually merge to form GlaxoSmithKline. He left a large amount of capital for charitable work in his will, which was used to form the Wellcome Trust, one of the world's largest medical charities. He was a keen collector of medical artefacts which are now managed by the Science Museum, London, and a small selection of which are displayed at the Wellcome Collection.

<span class="mw-page-title-main">Cambridge Biomedical Campus</span>

The Cambridge Biomedical Campus is the largest centre of medical research and health science in Europe. The site is located at the southern end of Hills Road in Cambridge, England.

Europe PubMed Central is an open-access repository which contains millions of biomedical research works. It was known as UK PubMed Central until 1 November 2012.

Malaria vaccines are vaccines that prevent malaria, a mosquito-borne infectious disease which annually affects an estimated 247 million people worldwide and causes 619,000 deaths. The first approved vaccine for malaria is RTS,S, known by the brand name Mosquirix. As of April 2023, the vaccine has been given to 1.5 million children living in areas with moderate-to-high malaria transmission. It requires at least three doses in infants by age 2, and a fourth dose extends the protection for another 1–2 years. The vaccine reduces hospital admissions from severe malaria by around 30%.

<span class="mw-page-title-main">Pardis Sabeti</span> Iranian American scientist

Pardis Christine Sabeti is an Iranian American computational biologist, medical geneticist, and evolutionary geneticist. She developed a bioinformatic statistical method which identifies sections of the genome that have been subject to natural selection and an algorithm which explains the effects of genetics on the evolution of disease.

<span class="mw-page-title-main">UCL Institute of Ophthalmology</span>

The pharmaceutical industry in the United Kingdom directly employs around 73,000 people and in 2007 contributed £8.4 billion to the UK's GDP and invested a total of £3.9 billion in research and development. In 2007 exports of pharmaceutical products from the UK totalled £14.6 billion, creating a trade surplus in pharmaceutical products of £4.3 billion.

Chetan Eknath Chitnis is an Indian scientist in the field of malaria research. He is the head of the Malaria Parasite Biology and Vaccines Unit at the Institut Pasteur in Paris and an elected fellow of the Indian Academy of Sciences (2009) as well as Indian National Science Academy (2014). He received the Shanti Swaroop Bhatnagar Award in 2004 and the Infosys Prize in Life Sciences 2010. Chitnis is the former principal investigator of the malaria research group at the International Centre for Genetic Engineering and Biotechnology (ICGEB) in New Delhi.

Russell J. Howard is an Australian-born executive, entrepreneur and scientist. He was a pioneer in the fields of molecular parasitology, especially malaria, and in leading the commercialisation of one of the most important methods used widely today in molecular biology today called “DNA shuffling" or "Molecular breeding", a form of "Directed evolution".

<span class="mw-page-title-main">Foundation for the National Institutes of Health</span>

The Foundation for the National Institutes of Health (FNIH) is a not-for-profit, 501(c)(3) charitable organization established by the US Congress in 1990. Located in North Bethesda, MD, the FNIH raises private-sector funds, and creates and manages alliances with public and private institutions in support of the mission of the National Institutes of Health (NIH).

<span class="mw-page-title-main">Akiko Iwasaki</span> Immunobiologist

Akiko Iwasaki is a Sterling Professor of Immunobiology and Molecular, Cellular and Developmental Biology at Yale University. She is also a principal investigator at the Howard Hughes Medical Institute. Her research interests include innate immunity, autophagy, inflammasomes, sexually transmitted infections, herpes simplex virus, human papillomavirus, respiratory virus infections, influenza infection, T cell immunity, commensal bacteria, COVID-19 and Long COVID.

<span class="mw-page-title-main">Julian Rayner</span> New Zealand malaria researcher

Julian Charles Rayner is a New Zealand malaria researcher, and the Director of the Cambridge Institute for Medical Research, part of the University of Cambridge School of Clinical Medicine. He is also Director of Wellcome Connecting Science. He was previously a member of academic Faculty at the Wellcome Sanger Institute.

The Coalition for Epidemic Preparedness Innovations (CEPI) is a foundation that takes donations from public, private, philanthropic, and civil society organisations, to finance independent research projects to develop vaccines against emerging infectious diseases (EID).

Alan Frederick Cowman AC, FRS, FAA, CorrFRSE, FAAHMS, FASP, FASM is an internationally acclaimed malaria researcher whose work specialises in researching the malaria-causing parasite, Plasmodium falciparum, and the molecular mechanisms it uses to evade host responses and antimalarial drugs. He is currently deputy directory of the Walter and Eliza Hall Institute of Medical Research (WEHI) in Melbourne, and his laboratory continues to work on understanding how Plasmodium falciparum, infects humans and causes disease. He was elected as a fellow of the Royal Society in 2011 and awarded the Companion of the Order of Australia in 2019 for his "eminent service to the biological sciences, notably to molecular parasitology, to medical research and scientific education, and as a mentor."

Kim Orth is a microbiologist and biochemist. She is the Earl A. Forsythe chair in biomedical science and professor of molecular biology and biochemistry at UT Southwestern. She is a Howard Hughes Medical Institute investigator and a member of the National Academy of Sciences. Her research focuses on bacterial pathogenesis.

Ana Rodriguez is a parasitologist and Professor in the Department of Microbiology at New York University School of Medicine. Her research focuses on Plasmodium falciparum and Trypanosoma cruzi and she is known for her work on Plasmodium liver infection, Plasmodium immunity, and T. cruzi drug development.

Maurizio Del Poeta is a Distinguished Professor in the Department of Microbiology and Immunology at the Stony Brook University Renaissance School of Medicine. His research focuses on novel anti-fungal drug discovery and lipid-mediated fungal pathogenesis.

Elizabeth Ashley is a British physician who is Director of the Laos-Oxford-Mahosot Hospital-Wellcome Trust Research Unit (LOMWRU) in Laos. She specialises in infectious diseases and medical microbiology and virology. She is an associate editor for the Malaria Journal and serves on the Council of the International Society for Infectious Diseases.

Sanjeev Krishna,, is a British physician and parasitologist whose research focuses on affordable diagnosis and treatment of diseases such as COVID-19, malaria, Ebola, African trypanosomiasis, leishmaniasis, and colorectal cancer. Krishna is Professor of Medicine and Molecular Parasitology at St George's, University of London and St George's Hospital.

References

  1. ↑ Proceeding of the BEST Practices Workshop. Retrieved on January 16, 2020
  2. ↑ Research Triangle Park Foundation. Retrieved on January 23, 2020
  3. ↑ Burroughs Wellcome Fund. Retrieved on January 23, 2020
  4. 1 2 "Burroughs Wellcome Fund | NCpedia". www.ncpedia.org. Retrieved 3 November 2023.
  5. ↑ "Assistant Professor Ivalyo Ivanov wins a Burroughs Wellcome Fund's Investigator in the Pathogenesis of Infectious Disease Award". Columbia University Department of Microbiology & Immunology. Retrieved 3 November 2023.
  6. ↑ "Burroughs Wellcome Fund award expands opportunities for physician-scientists". VUMC Reporter. Retrieved 3 November 2023.
  7. ↑ "Innovation in Regulatory Science Awards | Research Funding". Duke University Research Funding. Retrieved 3 November 2023.
  8. ↑ Institutes of Medicine. Retrieved on January 23, 2020.
  9. ↑ "Database Lets Researchers Worldwide Access the Genome of the Malarial Parasite Plasmodium falciparum". Penn Today. 20 October 2002. Retrieved 3 November 2023.
  10. ↑ "Strategies to Leverage Research Funding: Guiding DOD's Peer Reviewed Medical Research Programs". The National Academies Press: 44. 27 October 2004. doi:10.17226/11089 . Retrieved 3 November 2023.
  11. ↑ Murphy, Mary Kate (27 December 2019). "West Pine Teacher Mariah Morris Making Most of Her Statewide, National Platform". The Pilot Newspaper. Retrieved 3 November 2023.
  12. ↑ Dance, Amber (April 17, 2013). "Regulatory Science: Researchers in the Pipeline". Nature. 496 (7445): 387–9. doi: 10.1038/nj7445-387a . PMID   23646375.
This page is based on this Wikipedia article
Text is available under the CC BY-SA 4.0 license; additional terms may apply.
Images, videos and audio are available under their respective licenses.